FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791551144> ?p ?o ?g. }

• W2791551144 endingPage "43S" @default.
• W2791551144 startingPage "32S" @default.
• W2791551144 abstract "Background. As molecular subtyping of breast cancer influences clinical management, the evaluation of screening and adjuvant treatment interventions at the population level needs to account for molecular subtyping. Performing such analyses are challenging because molecular subtype-specific, long-term outcomes are not readily accessible; these markers were not historically recorded in tumor registries. We present a modeling approach to estimate historical survival outcomes by estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status. Method. Our approach leverages a simulation model of breast cancer outcomes and integrates data from two sources: the Surveillance Epidemiology and End Results (SEER) databases and the Breast Cancer Surveillance Consortium (BCSC). We not only produce ER- and HER2-specific estimates of breast cancer survival in the absence of screening and adjuvant treatment but we also estimate mean tumor volume doubling time (TVDT) and mean mammographic detection threshold by ER/HER2-status. Results. In general, we found that tumors with ER-negative and HER2-positive status are associated with more aggressive growth, have lower TVDTs, are harder to detect by mammography, and have worse survival outcomes in the absence of screening and adjuvant treatment. Our estimates have been used as inputs into model-based analyses that evaluate the effects of screening and adjuvant treatment interventions on population outcomes by ER and HER2 status developed by the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Working Group. In addition, our estimates enable a re-assessment of historical trends in breast cancer incidence and mortality in terms of contemporary molecular tumor characteristics. Conclusion. Our approach can be generalized beyond breast cancer and to more complex molecular profiles." @default.
• W2791551144 created "2018-03-29" @default.
• W2791551144 creator A5022829631 @default.
• W2791551144 creator A5042253328 @default.
• W2791551144 date "2018-03-19" @default.
• W2791551144 modified "2023-10-02" @default.
• W2791551144 title "Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment" @default.
• W2791551144 cites W1961026612 @default.
• W2791551144 cites W1983154689 @default.
• W2791551144 cites W2032365942 @default.
• W2791551144 cites W2032792437 @default.
• W2791551144 cites W2040935952 @default.
• W2791551144 cites W2044702943 @default.
• W2791551144 cites W2045216597 @default.
• W2791551144 cites W2072326013 @default.
• W2791551144 cites W2084348991 @default.
• W2791551144 cites W2093069046 @default.
• W2791551144 cites W2098775844 @default.
• W2791551144 cites W2099609524 @default.
• W2791551144 cites W2102596641 @default.
• W2791551144 cites W2104200572 @default.
• W2791551144 cites W2123460316 @default.
• W2791551144 cites W2126415088 @default.
• W2791551144 cites W2129044112 @default.
• W2791551144 cites W2132619562 @default.
• W2791551144 cites W2146384083 @default.
• W2791551144 cites W2148844662 @default.
• W2791551144 cites W2149908785 @default.
• W2791551144 cites W2151375530 @default.
• W2791551144 cites W2151827389 @default.
• W2791551144 cites W2154947819 @default.
• W2791551144 cites W2167926320 @default.
• W2791551144 cites W2282197435 @default.
• W2791551144 cites W2328747086 @default.
• W2791551144 cites W2512854569 @default.
• W2791551144 cites W2792841394 @default.
• W2791551144 cites W2792931869 @default.
• W2791551144 cites W332757656 @default.
• W2791551144 doi "https://doi.org/10.1177/0272989x17743236" @default.
• W2791551144 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6635303" @default.
• W2791551144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29554464" @default.
• W2791551144 hasPublicationYear "2018" @default.
• W2791551144 type Work @default.
• W2791551144 sameAs 2791551144 @default.
• W2791551144 citedByCount "25" @default.
• W2791551144 countsByYear W27915511442017 @default.
• W2791551144 countsByYear W27915511442018 @default.
• W2791551144 countsByYear W27915511442019 @default.
• W2791551144 countsByYear W27915511442020 @default.
• W2791551144 countsByYear W27915511442021 @default.
• W2791551144 countsByYear W27915511442022 @default.
• W2791551144 countsByYear W27915511442023 @default.
• W2791551144 crossrefType "journal-article" @default.
• W2791551144 hasAuthorship W2791551144A5022829631 @default.
• W2791551144 hasAuthorship W2791551144A5042253328 @default.
• W2791551144 hasBestOaLocation W27915511442 @default.
• W2791551144 hasConcept C107130276 @default.
• W2791551144 hasConcept C118552586 @default.
• W2791551144 hasConcept C120665830 @default.
• W2791551144 hasConcept C121332964 @default.
• W2791551144 hasConcept C121608353 @default.
• W2791551144 hasConcept C126322002 @default.
• W2791551144 hasConcept C143998085 @default.
• W2791551144 hasConcept C199360897 @default.
• W2791551144 hasConcept C27415008 @default.
• W2791551144 hasConcept C2777863537 @default.
• W2791551144 hasConcept C2780472235 @default.
• W2791551144 hasConcept C2908647359 @default.
• W2791551144 hasConcept C29456083 @default.
• W2791551144 hasConcept C41008148 @default.
• W2791551144 hasConcept C530470458 @default.
• W2791551144 hasConcept C61511704 @default.
• W2791551144 hasConcept C71924100 @default.
• W2791551144 hasConcept C83852419 @default.
• W2791551144 hasConcept C84606932 @default.
• W2791551144 hasConcept C99454951 @default.
• W2791551144 hasConceptScore W2791551144C107130276 @default.
• W2791551144 hasConceptScore W2791551144C118552586 @default.
• W2791551144 hasConceptScore W2791551144C120665830 @default.
• W2791551144 hasConceptScore W2791551144C121332964 @default.
• W2791551144 hasConceptScore W2791551144C121608353 @default.
• W2791551144 hasConceptScore W2791551144C126322002 @default.
• W2791551144 hasConceptScore W2791551144C143998085 @default.
• W2791551144 hasConceptScore W2791551144C199360897 @default.
• W2791551144 hasConceptScore W2791551144C27415008 @default.
• W2791551144 hasConceptScore W2791551144C2777863537 @default.
• W2791551144 hasConceptScore W2791551144C2780472235 @default.
• W2791551144 hasConceptScore W2791551144C2908647359 @default.
• W2791551144 hasConceptScore W2791551144C29456083 @default.
• W2791551144 hasConceptScore W2791551144C41008148 @default.
• W2791551144 hasConceptScore W2791551144C530470458 @default.
• W2791551144 hasConceptScore W2791551144C61511704 @default.
• W2791551144 hasConceptScore W2791551144C71924100 @default.
• W2791551144 hasConceptScore W2791551144C83852419 @default.
• W2791551144 hasConceptScore W2791551144C84606932 @default.
• W2791551144 hasConceptScore W2791551144C99454951 @default.
• W2791551144 hasFunder F4320337351 @default.
• W2791551144 hasIssue "1_suppl" @default.

• next